Intellectual Property

  • October 22, 2026

    Elsevier Beats Defamation Suit Over Air Purifier Article

    An indoor air quality company failed to prove academic publisher Elsevier acted with malice in printing an article questioning the effectiveness of its air purification technology sufficient to sustain a claim for defamation, a North Carolina federal judge ruled Thursday.

  • October 22, 2026

    10x Genomics Ends Patent Fight Against Parse In Delaware

    10x Genomics has told a Delaware federal judge it will no longer pursue a patent case against Parse Biosciences Inc. over methods of analyzing genetic information, a move following the Federal Circuit's refusal to revive the remaining three patents-at-issue.

  • October 22, 2026

    Ex-Eminem Employee Cops To Selling Unreleased Music

    A former employee of Detroit rapper Eminem pled guilty Thursday to taking and selling music the artist had not released for about $50,000.

  • October 22, 2026

    Fed. Circ. Won't Overrule Sending IP Cases From Va. To Ill.

    The Federal Circuit on Thursday said it won't send back to Virginia federal court a trio of suits accusing fleet vehicle telematics company Xirgo Technologies of infringing more than a dozen patents, keeping the cases in Illinois federal court.

  • October 22, 2026

    Imperative Gets PTAB To Trim Inari Medical Device Claims

    The Patent Trial and Appeal Board has invalidated claims in an Inari Medical Inc. patent on valves used in surgery to prevent blood loss, handing another win to challenger Imperative Care as it fends off an infringement lawsuit in California.

  • October 22, 2026

    Music Co. Accuses Anthropic Of Training Claude On Catalog

    A music holdings company has alleged that Anthropic trained its large language model Claude on copyrighted music by pirating songs from the internet and removing their copyright management information.

  • October 22, 2026

    DLA Piper Hires Shook Hardy Product Liability Partner

    DLA Piper has hired a former Shook Hardy & Bacon LLP product liability partner in San Francisco who has decades of experience defending companies in high-stakes disputes involving hundreds of millions of dollars.

  • October 21, 2026

    Iran Money Trail Takes Center Stage At Huawei's RICO Trial

    The federal jury in Brooklyn weighing Huawei's fate for days heard testimony about the money trail, or lack thereof, from the company's purported Iranian unit and the Chinese telecommunications giant's U.S. payroll, as one of its defenses in the sanctions and trade secret theft trial began to take shape.

  • October 21, 2026

    Amazon Says Chinese Videos Reveal TM Suit Payout Scheme

    Amazon has told a Chicago federal judge that it found Chinese-language videos and social media posts in which a China-based operator describes using federal lawsuits to release money from frozen seller accounts, offering a possible explanation for court-ordered transfers the e-commerce giant has challenged in more than a dozen trademark cases.

  • October 21, 2026

    Anthropic's Lyric 'Mash Up' May Be Fair Use, Judge Says

    A California federal judge Wednesday appeared open to Anthropic's defense that using copyrighted song lyrics to train Claude AI is fair use, saying during a daylong hearing that "mash-up" lyrics produced by AI might constitute fair use while also questioning how to "slice and dice" the case's scope.

  • October 21, 2026

    Law Firm Ordered To Hand Over Rebrand Records In TM Fight

    A personal injury law firm must turn over documents with information about its decision to rebrand and search the personal devices of its CEO and vice president in a trademark battle with another firm, a North Carolina magistrate judge has ruled.

  • October 21, 2026

    Detroit Lions Can't Sack 'Motor City Muscle' TM Claims

    A Michigan federal judge on Tuesday trimmed U.S. Events LLC's lawsuit against the Detroit Lions, but ruled that the team must face claims of trademark infringement and unfair competition over its use of the company's protected "Motor City Muscle" slogan to promote its jerseys.

  • October 21, 2026

    Chinese Light Makers Reach Deal After $1.5M Patent Verdict

    Chinese company Jiaxing Super Lighting has reached a deal to end a patent lawsuit over LED tube lamp products after a Texas federal jury earlier this year awarded the business $1.5 million in damages for infringing one of its patents.

  • October 21, 2026

    House Bill Looks To Ease Copyright Process For Visual Artists

    Visual artists like photographers would have a more streamlined and cheaper copyright registration process under a bill that has been introduced in the U.S. House of Representatives, matching a similar bill floated last year in the U.S. Senate.

  • October 21, 2026

    Via, RideCo Settle Ride-Hailing IP Case After $4M Judgment

    Canadian ride-hailing software startup RideCo Inc. said Wednesday that it had reached a settlement with rival Via Transportation to close a patent infringement case after a jury issued a $1.4 million award to Via that was later boosted to $4 million.

  • October 21, 2026

    Dish Gets Carrier Signal Patent Invalidated Under Alice

    A Delaware federal judge has ruled that a patent covering carrier signal technology that Dish Network is accused of infringing is invalid under the Supreme Court's Alice test, but found that a second patent isn't invalid as abstract.

  • October 21, 2026

    Marex Says Developer Sank CME Ventures Investment Deal

    Financial services firm Marex Capital Markets and two of its executives have sued a British software developer in Illinois federal court, alleging the developer sabotaged a potential investment by CME Group's venture capital arm in Marex's options-trading platform by secretly accusing them of stealing trade secrets, committing fraud and violating exchange rules.

  • October 21, 2026

    Amarin Ends 'Skinny Label' Patent Case Against Hikma

    Amarin Pharma Inc. is dropping its patent suit over Hikma Pharmaceuticals USA Inc.'s generic version of a heart drug that uses a so-called skinny label, months after the U.S. Supreme Court shut the case down.

  • October 21, 2026

    Mewburn Ellis Appoints CTO To Drive Further AI Adoption

    Mewburn Ellis LLP announced Wednesday the appointment of its first-ever chief technology officer, who will be responsible for the intellectual property firm's technology strategy, artificial intelligence adoption and digital transformation.

  • October 21, 2026

    Italian Winery Asks Justices To Revive TM Victory

    An Italian winery has urged the U.S. Supreme Court to restore a trademark infringement ruling it won in New York federal court that was later overturned by the Second Circuit, saying the circuit had misapplied the justices' guidance for finding trademark preclusion.

  • October 20, 2026

    Ashley St. Clair Can't Toss XAI Forum Clause Suit

    A Texas federal judge refused Tuesday to dismiss xAI's lawsuit accusing political commentator and influencer Ashley St. Clair of violating its terms of service by suing in New York over allegations that Grok generated sexually explicit images of her.

  • October 20, 2026

    'Extraordinary' Design Patent Expert Perry Saidman Dies At 81

    Perry J. Saidman, a vanguard in the field of design patent law and described by his peers as a one-of-a-kind "mensch" with a quick wit and sharp sense of humor, has died. He was 81.

  • October 20, 2026

    Squires Grants 10 Patent Review Bids, Rejects 2 Others

    In his latest round of decisions, U.S. Patent and Trademark Office Director John Squires has granted 10 petitions seeking review of patents and denied two others, both on discretionary grounds.

  • October 20, 2026

    Genentech, Novartis Sue Amneal Over Bid To Sell Xolair Copy

    Genentech Inc. and Novartis Pharmaceuticals Corp. have filed a patent infringement suit in Delaware federal court, claiming Kashiv BioSciences' bid to sell a biosimilar copy of their prescription allergy drug Xolair amounts to patent infringement.

  • October 20, 2026

    Squires Orders Remand Of Partial Tesla Win On Camera IP

    U.S. Patent and Trademark Office Director John Squires has thrown out part of a Patent Trial and Appeal Board decision that Tesla showed some claims in a digital camera technology patent were invalid, saying the board has to take another look.

Expert Analysis

  • Series

    Mentalism Makes Me A Better Lawyer

    Author Photo

    Convincing strangers I can read their minds may seem like an unusual second career for a legal practitioner, but both disciplines share several important requirements, including trust and preparation, says Warren Biro at Manatt.

  • Why And How To Build A Neurodiversity-Informed Practice

    Author Photo

    By better understanding neurodiversity and implementing simple accommodations for clients with autism, ADHD or learning differences, attorneys can build stronger relationships with those who may otherwise struggle to obtain and benefit from legal services, while developing good habits that will benefit everyone they represent, says Ting Cheung at Sanford Heisler.

  • How Public Filing Pilot Is Influencing Litigation Strategy

    Author Photo

    The ongoing pilot program that makes it easier for third parties like journalists or academics to obtain court documents used in certain public hearings is reshaping how litigation teams draft skeleton arguments, settle expert evidence, and identify and restrict sensitive material, say lawyers at Greenberg Traurig.

  • Opinion

    PTAB Panels Should Revamp Their IPR Merits Decisions

    Author Photo

    In light of U.S. Patent and Trademark Office Director John Squires' recent announcement about returning merits institution determinations to the Patent Trial and Appeal Board, the implementing framework should strengthen PTAB panels' responsibility for the benefit of both petitioners and patent owners, says Brandon Theiss at AddyHart.

  • Patent Eligibility Bulletin: Claim Solutions, Not Results

    Author Photo

    In the third quarter of the year, two Federal Circuit decisions illustrated that claims sharing the same disclosure can fall on opposite sides of the patent eligibility line, depending on the specific nuances of tech patents' claims, says Reilley Keane at Banner Witcoff.

  • New DNA Screening Standard Has No Clear Playbook

    Author Photo

    Although the government has not yet released promised guidance intended to support its new standards for screening mail-order DNA, companies should not read this as a reprieve from the Oct. 13 compliance deadline because the delay shifts enforcement risk to statutes that need no new authority, including false statements, the False Claims Act and fraud, says Ashwin Ram at Buchalter.

  • Opinion

    Clancy Trial Shows Need For Juror Anonymity Reforms

    Author Photo

    Doxing of the holdout juror in the Lindsay Clancy murder mistrial in Massachusetts illustrates the increasing need to provide jurors with greater protection once service ends in high-profile cases, balancing concerns about transparency and independence, says Daniel Schneider at Offit Kurman.

  • The Patent Circuit: Marking Duties For Licensed Tech

    Author Photo

    The Federal Circuit's decision in VDPP v. Volkswagen provides clarity on how the patent statute's marking provision applies to licensed technology, but expressly leaves open the question of how exactly patentees can make reasonable efforts to ensure licensees' marking compliance, say attorneys at Knobbe Martens.

  • Testing AI's Promise For Large-Scale Document Review

    Author Photo

    Our document-review comparison of attorneys' responsiveness and issue coding decisions versus predictions generated by artificial intelligence across 1,600 documents suggests that these tools can offer a reasonable and reliable basis for improved discovery workflows, provided lawyers understand where guardrails are needed, say attorneys at Redgrave.

  • Navigating A Key Inflection Point In Biosimilar Sector M&A

    Author Photo

    As biosimilar mergers and acquisitions gain notice amid U.S. Food and Drug Administration reforms, a maturing patent framework and a looming patent cliff, companies diversifying into the higher-growth biologics space should align their regulatory, intellectual property and transactional strategies, say attorneys at Skadden.

  • AI Meeting Recaps Pose New Discovery And Privilege Risks

    Author Photo

    The New York City Bar Association’s recent ethics opinion, cautioning attorneys not to record nonclient conversations with artificial intelligence tools, reflects an emerging view that AI meeting recaps are now a distinct business record category, meaning counsel should set meeting-level controls and apply framework-level updates, says William Wright at Faegre Drinker.

  • Class Actions At The Circuit Courts: September Lessons

    Author Photo

    In this month's review of class action appeals, Mitchell Engel at Shook Hardy discusses six recent rulings involving pecuniary loss in false price comparison advertising, privity in an insurance fee class, antitrust standing, immigration class representatives, retirement beneficiary class commonality, and Rule 23(f) appeals in Fair Labor Standards Act claims.

  • First Steps For Companies Facing AI-Assisted Pro Se Suits

    Author Photo

    As the volume of filings by pro se litigants assisted by artificial intelligence tools continues to increase, companies should adopt a consistent early assessment process to control costs while responding fairly and effectively to such claims, say attorneys at Stradley Ronon.

  • Beware Daubert Pitfalls With Technical Experts In Patent Suits

    Recent decisions on Daubert motions in patent cases show that courts will exclude expert testimony that lacks a solid factual or methodological foundation, regardless of the expert's credentials — underscoring the importance of demonstrating reliability, say attorneys at Steptoe.

  • Wireless Patent Suits Offer Lessons For Data Center Industry

    Author Photo

    As the data center patent litigation wave begins to crest, the industry can gain insight into what's to come by looking to the wireless and telecommunications industries, giving operators and suppliers concrete reasons to revisit their agreements and establish clear allocations of patent risk, say attorneys at Baker Botts.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Intellectual Property archive.